Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
10 participants
INTERVENTIONAL
2018-07-23
2018-07-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
INVSENSOR00027 Clinical Performance Study
NCT03650192
INVSENSOR00032 and INVSENSOR00033 Respiration Rate Clinical Performance Study
NCT03897179
Convenience Sample Data Collection for INVSENSOR00045
NCT04894669
INVSENSOR00013 Respiratory Rate Clinical Performance Study
NCT03440619
Clinical Validation for SpO2 Function of Masimo INVSENSOR00069
NCT06120777
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
INVSENSOR00011 Test group
The subjects will be enrolled into the test group and will receive the INVSENSOR00011 investigational sensor.
INVSENSOR00011
INVSENSOR00011 - investigational sensor that will be placed on the subject's chest and/or back for the duration of the study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
INVSENSOR00011
INVSENSOR00011 - investigational sensor that will be placed on the subject's chest and/or back for the duration of the study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physical status of ASA I or II
* Must be able to read and communicate in English
* Has signed all necessary related documents, e.g. written informed consent, health assessment questionnaire, gender and ethnicity form, confidentiality agreement
* Passed health assessment screening
Exclusion Criteria
* Inability to tolerate sitting still or minimal movement for at least 30 minutes
* Nursing female volunteers
* Excluded at the Principal Investigator's discretion
* Refusal to take pregnancy test (for female subjects)
* Positive pregnancy tests for female subjects of child bearing potential.
* Refusal to shave hair off areas where sensors will be applied (male subjects)
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Masimo Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Masimo Clinical Lab
Irvine, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TP-19045A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.